---

Chairman, President, and CEO, Aligos Therapeutics

A veteran of the hepatology and virology space, Lawrence is a key and proven expert in both sectors. He has successfully progressed drugs from the bench to the market, and is on track to do so again with Aligos’ portfolio of potential best-in-class drugs for liver and viral diseases. Many of his team members have been with him at multiple companies, including Janssen. He says that he aims to inspire those around him through the provision of the tools and mentorship that turn bold ideas into transformative technologies.

“I firmly believe by giving young scientists the tools and guidance they need to succeed, we can empower them to turn bold ideas into reality. This is a philosophy I live by as the CEO of Aligos – I’m committed to shaping the next generation by sharing insights from my career on what’s worked and what’s failed, and by providing guidance on bold ideas that have the potential to transform the future of medicine.”